Intermittent fasting can enhance fat burning, improve insulin sensitivity, and support long-term weight management
For example, encapsulation of Liraglutide, a long-acting GLP-1, in PLGA NPs significantly protected the drug from degradation in simulated gastric and intestinal fluids
This combined approach ensures accurate purity assessment, aiding in method validation and regulatory compliance in peptide production
On 21 May 2026 , Lilly published the long-awaited topline results from the TRIUMPH-1 Phase 3 trial, and the data is striking: participants on the highest dose lost an average of 28.3% of their body weight at 80 weeks , with 45.3% of patients losing 30% or more a threshold previously only achievable with bariatric surgery
were even less enthusiastic